1. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1994, 12, 2471–2508.
2. DeVita VT Jr. Principles of cancer management: chemotherapy. In DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 5th edn. Philadelphia, Lippincott-Raven, 1997, 333–347.
3. Norton L. Evolving concepts in the systemic drug therapy of breast cancer. Semin Oncol 1997, 24(Suppl. 10), S10-3–S10-10.
4. Skipper H. Data and analyses having to do with the influence of dose intensity and duration of treatment (single drugs and combinations) on lethal toxicity and therapeutic response of experimental neoplasms. Southern Research Institute Booklet 13. Birmingham, Alabama, USA, Southern Research Institute, 24 December 1986. [NB - the reference is the whole booklet.]
5. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer;Hryniuk;J. Clin. Oncol.,1986